S. Mura Et Al. , "In vitro investigation of multidrug nanoparticles for combined therapy with gemcitabine and a tyrosine kinase inhibitor: Together is not better," BIOCHIMIE , vol.130, pp.4-13, 2016
Mura, S. Et Al. 2016. In vitro investigation of multidrug nanoparticles for combined therapy with gemcitabine and a tyrosine kinase inhibitor: Together is not better. BIOCHIMIE , vol.130 , 4-13.
Mura, S., Buchy, E., Askin, G., Cayre, F., Mougin, J., Gouazou, S., ... Sobot, D.(2016). In vitro investigation of multidrug nanoparticles for combined therapy with gemcitabine and a tyrosine kinase inhibitor: Together is not better. BIOCHIMIE , vol.130, 4-13.
Mura, Simona Et Al. "In vitro investigation of multidrug nanoparticles for combined therapy with gemcitabine and a tyrosine kinase inhibitor: Together is not better," BIOCHIMIE , vol.130, 4-13, 2016
Mura, Simona Et Al. "In vitro investigation of multidrug nanoparticles for combined therapy with gemcitabine and a tyrosine kinase inhibitor: Together is not better." BIOCHIMIE , vol.130, pp.4-13, 2016
Mura, S. Et Al. (2016) . "In vitro investigation of multidrug nanoparticles for combined therapy with gemcitabine and a tyrosine kinase inhibitor: Together is not better." BIOCHIMIE , vol.130, pp.4-13.
@article{article, author={Simona Mura Et Al. }, title={In vitro investigation of multidrug nanoparticles for combined therapy with gemcitabine and a tyrosine kinase inhibitor: Together is not better}, journal={BIOCHIMIE}, year=2016, pages={4-13} }